IL-17A production can dismantle the anti-tumor functionality of IFNγ-producing γδ T cells, and Tγδ17 cells have been associated with tumor progression and poor outcomes in multiple tumor types [31,88]; however, the mechanism by which this occurs in humans is not fully understood. This evidence concerns the gene IFNG and neoplasm.